Carol E. Jolly
Liverpool, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Mitotoxic effects of the melanin-concentrating hormone receptor 1 (MCHr1) antagonist AZD1979 are influenced by mitochondrial DNA variation in HepG2 cybrids.
Journal: Toxicology
Published: September 25, 2025
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens-Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review.
Journal: Current opinion in allergy and clinical immunology
Published: May 16, 2024
TNF-α induced extracellular release of keratinocyte high-mobility group box 1 in Stevens-Johnson syndrome/toxic epidermal necrolysis: Biomarker and putative mechanism of pathogenesis.
Journal: The Journal of dermatology
Published: February 10, 2023
TNF-α‒Mediated Keratinocyte Expression and Release of Matrix Metalloproteinase 9: Putative Mechanism of Pathogenesis in Stevens‒Johnson Syndrome/Toxic Epidermal Necrolysis.
Journal: The Journal of investigative dermatology
Published: April 04, 2022
The generation of HepG2 transmitochondrial cybrids to reveal the role of mitochondrial genotype in idiosyncratic drug-induced liver injury.
Journal: eLife
Published: February 25, 2022
Checkpoint Inhibition Reduces the Threshold for Drug-Specific T-Cell Priming and Increases the Incidence of Sulfasalazine Hypersensitivity.
Journal: Toxicological sciences : an official journal of the Society of Toxicology
Published: December 01, 2021
T cell mediated hypersensitivity to previously tolerated iodinated contrast media precipitated by introduction of atezolizumab.
Journal: Journal for immunotherapy of cancer
Published: May 06, 2021
Identification of neutralising pembrolizumab anti-drug antibodies in patients with melanoma.
Journal: Scientific reports
Published: February 26, 2021
The utility of a differentiated preclinical liver model, HepaRG cells, in investigating delayed toxicity via inhibition of mitochondrial-replication induced by fialuridine.
Journal: Toxicology and applied pharmacology
Published: May 27, 2020
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis.
Journal: Clinical and experimental immunology
Published: March 16, 2020
Acute Metabolic Switch Assay Using Glucose/Galactose Medium in HepaRG Cells to Detect Mitochondrial Toxicity.
Journal: Current protocols in toxicology
Published: May 07, 2019
The utility of HepaRG cells for bioenergetic investigation and detection of drug-induced mitochondrial toxicity.
Journal: Toxicology in vitro : an international journal published in association with BIBRA
Published: March 23, 2018
Last Updated: 09/26/2026